Ann: FDA Grants Breakthrough Device Designation for Renal Failure, page-17

Hi There,

Let me assure I was in no way trying to minimising the benefit of SOZO for Lymphedema patients.

What I personally believe is that the market is more attuned to Renal and Heart products than lymphedema. I was not addressing what the company says about addressable markets but about pure perception of the common trader.

Most people know about Renal and Heart disease and treatments. Unfortunately and I do think it is unfortunate Lymphedema its causes, side effects and treatments not as widely known.

I'm a big believer in the company and all of the product here covering all treatments. Any progression in share price is good in my opinion and what the catalyst is I dont really mind

Keep Smiling Puk